Non-Billable / Non-Specific Code
ICD-10-CM D17 is the diagnosis code for Benign lipomatous neoplasm. This code falls under the section "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where D17 sits in the ICD-10-CM classification helps ensure proper coding:
No, D17 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
D17 is the ICD-10-CM diagnosis code for "Benign lipomatous neoplasm". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
D17 is located in Section D10-D36 — "Benign neoplasms, except benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
D17 has 9 sub-code(s) that provide more specific detail: D17.0, D17.1, D17.2, D17.3, D17.4 and more.
Use D17 when the patients documented diagnosis matches "Benign lipomatous neoplasm" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign lipomatous neoplasm is D17.
No, D17 is non-billable. Use a more specific sub-code for primary diagnosis billing.
D17 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D17 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.